Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Suvercha Pasricha"'
Autor:
Victor M. Tang, Kathleen Trought, Kristina M. Gicas, Mari Kozak, Sheena A. Josselyn, Zafiris J. Daskalakis, Daniel M. Blumberger, Daphne Voineskos, Yuliya Knyahnytska, Suvercha Pasricha, Yuan Chung, Young Zhou, Moshe Isserles, Albert H.C. Wong
Publikováno v:
Brain Stimulation, Vol 14, Iss 3, Pp 635-642 (2021)
Background: Post-traumatic Stress Disorder (PTSD) often does not respond to available treatments. Memories are vulnerable to disruption during reconsolidation, and electroconvulsive therapy (ECT) has amnestic effects Objective/hypothesis: To test the
Externí odkaz:
https://doaj.org/article/383e53c52400473194ed362c3dd12d9c
Autor:
Albert H.C. Wong, Moshe Isserles, Kristina M. Gicas, Victor M. Tang, Suvercha Pasricha, Yuan Chung, Kathleen Trought, Daphne Voineskos, Zafiris J. Daskalakis, Daniel M. Blumberger, Yuliya Knyahnytska, Mari Kozak, Young Zhou, Sheena A. Josselyn
Publikováno v:
Brain Stimulation, Vol 14, Iss 3, Pp 635-642 (2021)
Background Post-traumatic Stress Disorder (PTSD) often does not respond to available treatments. Memories are vulnerable to disruption during reconsolidation, and electroconvulsive therapy (ECT) has amnestic effects Objective/hypothesis To test the u
Autor:
Akash N. Pasricha, Suvercha Pasricha, Victor M. Tang, Zafiris J. Daskalakis, Daniel M. Blumberger, Daphne Voineskos, Benoit H. Mulsant
Publikováno v:
The Journal of ECT. 33:237-242
Objective This study aims to investigate the clinical effects of benzodiazepines or anticonvulsant use during a course of electroconvulsive therapy (ECT). Method A case report study of a patient who received ECT with and without concomitant flurazepa
Autor:
Charlie T.G. Campbell, Jing Liu, Shupeng Li, Kerry J. Ressler, Frankie H. F. Lee, Suvercha Pasricha, Ping Su, Dongxu Zhai, Anlong Jiang, Fang Liu, Terence K. Y. Lai, Albert H.C. Wong, Haiyin Li, WeiDong Yong
Publikováno v:
J Clin Invest
Posttraumatic stress disorder (PTSD) can develop after exposure to severe psychological trauma, leaving patients with disabling anxiety, nightmares, and flashbacks. Current treatments are only partially effective, and development of better treatments
Autor:
Jeffrey H. Meyer, Nathan J. Kolla, Jalpa Patel, Paul S. Links, Charis Kellow, Paraskevi V. Rekkas, Shelley McMain, R. Michael Bagby, Suvercha Pasricha, Alan A. Wilson, Sylvain Houle, Lina Chiuccariello
Publikováno v:
Biological Psychiatry. 79:117-126
Background Monoamine oxidase-A (MAO-A) is a treatment target in neurodegenerative illness and mood disorders that increases oxidative stress and predisposition toward apoptosis. Increased MAO-A levels in prefrontal cortex (PFC) and anterior cingulate